Compare HRMY & SRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HRMY | SRCE |
|---|---|---|
| Founded | 2017 | 1863 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 2020 | 1995 |
| Metric | HRMY | SRCE |
|---|---|---|
| Price | $31.52 | $73.76 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 4 |
| Target Price | $44.11 | ★ $74.50 |
| AVG Volume (30 Days) | ★ 651.7K | 85.7K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.37% |
| EPS Growth | 7.97 | ★ 19.59 |
| EPS | 0.55 | ★ 1.63 |
| Revenue | ★ $868,453,000.00 | N/A |
| Revenue This Year | $19.75 | $10.29 |
| Revenue Next Year | $12.88 | $3.16 |
| P/E Ratio | $57.36 | ★ $44.99 |
| Revenue Growth | ★ 21.51 | N/A |
| 52 Week Low | $25.52 | $56.89 |
| 52 Week High | $40.87 | $76.44 |
| Indicator | HRMY | SRCE |
|---|---|---|
| Relative Strength Index (RSI) | 56.34 | 55.07 |
| Support Level | $25.92 | $71.36 |
| Resistance Level | $33.11 | $75.42 |
| Average True Range (ATR) | 0.93 | 1.59 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 87.38 | 57.96 |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
1st Source Corp provides specialized financing services for construction equipment, aircraft, and vehicle types through its Specialty Finance activities. The company offers commercial, small business, agricultural, and real estate loans, along with commercial leasing, treasury management, and payment services, including Fedwires, ACH, and merchant services. It also provides Renewable Energy Financing for commercial solar projects, a full range of consumer banking products, Trust and Wealth Advisory Services, and insurance products. The company operates in the commercial banking segment, which provides commercial and consumer banking services, trust and wealth advisory services, and insurance to individual and business clients across its markets.